Skip to main content
logo
BlackRock Health Sciences Trust (BME)
NYSE: BME · Real-Time Price · USD
44.60
+0.11 (0.25%)
Sep 21, 2026, 2:44 PM EDT - Market open

BME Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
76.9723.4520.02-26.4759.12
Loss (Gain) From Sale of Investments
-75.12-22.39-18.0128.05-59.12
Other Operating Activities
5263.9530.77-2.78-21.8
Change in Accounts Receivable
-0.030.22-0.02-0.160.01
Change in Income Taxes
----0.010.01
Change in Other Net Operating Assets
0.770.29-0.750.50.23
Operating Cash Flow
54.5865.5232.02-0.87-21.56
Operating Cash Flow Growth
-16.69%104.63%---

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--0.060-
Total Debt Issued
--0.060-
Short-Term Debt Repaid
--0.06---
Total Debt Repaid
--0.06---
Net Debt Issued (Repaid)
--0.060.060-
Issuance of Common Stock
--3.0233.6250.33
Repurchase of Common Stock
-13.98-29.53---
Common Dividends Paid
-40.61-35.92-35.1-32.73-29
Other Financing Activities
---0-0.020.02
Financing Cash Flow
-54.59-65.52-32.020.8821.34

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0-0-00-0
Net Cash Flow
-0.010.01-00-0.21

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
-1.96-2.154.66-15.812.28
Unlevered Free Cash Flow
-1.96-2.154.66-15.812.28

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
000--
Change in Working Capital
0.740.51-0.770.330.25
SEC Filings: 10-K · 10-Q